SEC reporting owner

Polaris Venture Partners Entrepreneurs' Fund V, L.P. SEC insider disclosures

Explore Polaris Venture Partners Entrepreneurs' Fund V, L.P.'s reporting-owner identity, issuer relationships, purchases, sales and SEC filing receipts.

As of 2026-10-07T00:29:11.873Z

Reporting owner CIK
0001439587
Issuers
17
Coverage
verified

Issuer relationships

A reporting-owner CIK identifies the filer across issuer relationships and name aliases. A filer may be an individual or an organization; the filing role is the relevant evidence.

INTERNET BRANDS, INC.0001080131INETNoNo
BIND Therapeutics, Inc0001385228BINDNoNo
FATE THERAPEUTICS INC0001434316FATENoNo
TREVENA INC0001429560TRVNNoNo
GENOCEA BIOSCIENCES, INC.0001457612GNCANoNo
Cerulean Pharma Inc.0001401914CERUNoNo
OCULAR THERAPEUTIX, INC0001393434OCULNoNo
T2 Biosystems, Inc.0001492674TTOONoNo
aTYR PHARMA INC0001339970LIFENoNo
Pulmatrix, Inc.0001574235PULMNoNo
SELECTA BIOSCIENCES INC0001453687SELBNoNo
Kala Pharmaceuticals, Inc.0001479419KALANoNo
Arsanis, Inc.0001501697ASNSNoNo
Cardlytics, Inc.0001666071CDLXNoYes
Phreesia, Inc.0001412408PHRNoNo
Lyra Therapeutics, Inc.0001327273LYRANoNo
Adagio Therapeutics, Inc.0001832038ADGINoNo

Recent SEC transactions

Code P identifies a purchase, S a sale and A an award. Awards and open-market purchases describe different events. Use the public availability date when deciding when a researcher could have known about the transaction.

No records are available for this view.

Up to 50 transactions from the recent two-year owner window.

Source evidence and strategy eligibility

The transactions below come from filings; a historical tracker separately simulates following eligible events. Joint filers can report the same transaction, and an owner can have filings at multiple companies. Public availability, amendment lineage and verified coverage determine which events a historical tracker may use.

The current directory marks this owner's filing coverage verified.